Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
Stopped The study was terminated because of slow enrollment. The decision to terminate the trial was not based on any safety or efficacy concerns.
Conditions
Interventions
- DRUG: Donepezil
- DRUG: Placebo
Sponsor
Pfizer